Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 20 July 2010
Vol. 3, Issue 131, p. ra54
[DOI: 10.1126/scisignal.2000807]
RESEARCH ARTICLES
Editor's Summary
Drug-Induced Heteromers
Opioid receptors are G protein–coupled receptors and are divided into µ, , and subtypes. Homomers of µ or receptors signal through a Gi-mediated pathway; however, these receptor subtypes can also form heteromers that signal through Gz- or β-arrestin2–mediated pathways. Although morphine analgesia is mediated primarily through the µ receptor, receptor ligands can potentiate µ receptor–mediated signaling, suggesting that the µ- heteromer may also be involved in morphine analgesia. Gupta et al. developed an antibody that selectively recognizes µ- heteromers and found that the abundance of the µ- heteromer in mice increased with chronic administration of morphine. These increases were detected in regions of the brain that are involved in the modulation of pain transmission. These results suggest that the µ- heteromer may be a candidate for therapies to alleviate chronic pain syndromes.
Citation: A. Gupta, J. Mulder, I. Gomes, R. Rozenfeld, I. Bushlin, E. Ong, M. Lim, E. Maillet, M. Junek, C. M. Cahill, T. Harkany, L. A. Devi, Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration. Sci. Signal.3, ra54 (2010).
Nancy R. Gough (24 April 2012) Sci. Signal.5 (221), ec116.
[DOI: 10.1126/scisignal.2003157] |Abstract »
EDITORS' CHOICE
Wei Wong (6 December 2011) Sci. Signal.4 (202), ec342.
[DOI: 10.1126/scisignal.4202ec342] |Abstract »
EDITORIAL GUIDES
Nancy R. Gough (9 August 2011) Sci. Signal.4 (185), eg7.
[DOI: 10.1126/scisignal.2002388] |Abstract »|Full Text »|PDF »
PERSPECTIVES
Nevin A. Lambert (30 March 2010) Sci. Signal.3 (115), pe12.
[DOI: 10.1126/scisignal.3115pe12] |Abstract »|Full Text »|PDF »
PERSPECTIVES
MacDonald J. Christie and Christophe Mallet (15 September 2009) Sci. Signal.2 (88), pe57.
[DOI: 10.1126/scisignal.288pe57] |Abstract »|Full Text »|PDF »
Novel Screening Assay for the Selective Detection of G-Protein-Coupled Receptor Heteromer Signaling.
R. M. van Rijn, J. H. Harvey, D. I. Brissett, J. N. DeFriel, and J. L. Whistler (2013)
J. Pharmacol. Exp. Ther.
344, 179-188
|Abstract »|Full Text »|PDF »
Functional Homomers and Heteromers of Dopamine D2L and D3 Receptors Co-exist at the Cell Surface.
C. Pou, C. Mannoury la Cour, L. A. Stoddart, M. J. Millan, and G. Milligan (2012)
J. Biol. Chem.
287, 8864-8878
|Abstract »|Full Text »|PDF »
Cys-27 Variant of Human {delta}-Opioid Receptor Modulates Maturation and Cell Surface Delivery of Phe-27 Variant via Heteromerization.
T. T. Leskela, J. J. Lackman, M. M. Vierimaa, H. Kobayashi, M. Bouvier, and U. E. Petaja-Repo (2012)
J. Biol. Chem.
287, 5008-5020
|Abstract »|Full Text »|PDF »
Chronic Methadone Treatment Shows a Better Cost/Benefit Ratio than Chronic Morphine in Mice.
J. Enquist, M. Ferwerda, L. Milan-Lobo, and J. L. Whistler (2012)
J. Pharmacol. Exp. Ther.
340, 386-392
|Abstract »|Full Text »|PDF »
Allosteric Interactions between {delta} and {kappa} Opioid Receptors in Peripheral Sensory Neurons.
K. A. Berg, M. P. Rowan, A. Gupta, T. A. Sanchez, M. Silva, I. Gomes, B. A. McGuire, P. S. Portoghese, K. M. Hargreaves, L. A. Devi, et al. (2012)
Mol. Pharmacol.
81, 264-272
|Abstract »|Full Text »|PDF »
Activation of Spinal {micro}- and {delta}-Opioid Receptors Potently Inhibits Substance P Release Induced by Peripheral Noxious Stimuli.
Heteromerization of the {micro}- and {delta}-Opioid Receptors Produces Ligand-Biased Antagonism and Alters {micro}-Receptor Trafficking.
L. Milan-Lobo and J. L. Whistler (2011)
J. Pharmacol. Exp. Ther.
337, 868-875
|Abstract »|Full Text »|PDF »
G Protein-Coupled Receptor Heteromerization: A Role in Allosteric Modulation of Ligand Binding.
I. Gomes, A. P. IJzerman, K. Ye, E. L. Maillet, and L. A. Devi (2011)
Mol. Pharmacol.
79, 1044-1052
|Abstract »|Full Text »|PDF »
A Unique Role of RGS9-2 in the Striatum as a Positive or Negative Regulator of Opiate Analgesia.
K. Psigfogeorgou, D. Terzi, M. M. Papachatzaki, A. Varidaki, D. Ferguson, S. J. Gold, and V. Zachariou (2011)
J. Neurosci.
31, 5617-5624
|Abstract »|Full Text »|PDF »